Holen Sie sich die Stockscreener-App
1.24
5.08%
0.06
Vorhandelsmarkt:
1.25
0.01
+0.81%
Schlusskurs vom Vortag:
$1.18
Offen:
$1.19
24-Stunden-Volumen:
355.13K
Relative Volume:
0.48
Marktkapitalisierung:
$3.01M
Einnahmen:
$212.10K
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-0.000233
EPS:
-5313.2836
Netto-Cashflow:
$-13.92M
1W Leistung:
+6.44%
1M Leistung:
-6.77%
6M Leistung:
-95.68%
1J Leistung:
-99.99%
1-Tages-Spanne:
$1.17
$1.25
1-Wochen-Bereich:
$1.1303
$1.30
52-Wochen-Spanne:
$1.05
$21,400.00
Aditxt Inc Stock (ADTX) Company Profile
Firmenname
Aditxt Inc
Sektor
Branche
Telefon
909-488-0844
Adresse
737 N. FIFTH STREET, SUITE 200, RICHMOND
Vergleichen Sie ADTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.24 | 2.83M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Aditxt Inc Aktie (ADTX) Neueste Nachrichten
Aditxt Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
What drives Aditxt Inc. stock priceConsistent triple-digit returns - Autocar Professional
Is Aditxt Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Aditxt to Present at Wall Street Reporter’s Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET - Business Wire
Aditxt Showcases Pearsanta’s Diagnostic Advancements - TipRanks
What analysts say about Aditxt Inc. stockExceptional trading results - Autocar Professional
Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - MarketScreener
Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - Benzinga
Aditxt CEO Discusses Strategic Initiatives at Livestream - MSN
Aditxt unveils bitcoin-backed strategy to support biotech ventures - Investing.com Australia
Aditxt launches Bitcoin treasury strategy to fund biotech ventures - Investing.com Australia
Aditxt launches Bitcoin treasury strategy to fund biotech ventures By Investing.com - Investing.com South Africa
Aditxt, Inc. Unveils bitXbio - MarketScreener
Aditxt unveils bitcoin-backed strategy to support biotech ventures By Investing.com - Investing.com South Africa
Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization - The Globe and Mail
Evofem Biosciences Enters Securities Purchase Agreement - TipRanks
Aditxt CEO Discusses Strategic Growth at Livestream Event - The Globe and Mail
Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET - Business Wire
Appili Therapeutics: Navigating Biodefense Challenges Amid Strategic Shifts - AInvest
Aditxt Inc. Integrates Bitcoin into Treasury Strategy with 302 Mentions in SEC Filing - AInvest
Aditxt Incorporates Bitcoin Focused Digital Asset Strategy - AInvest
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board - citybiz
Aditxt Inc. Strengthens Board with Appointment of Evofem CEO Saundra Pelletier - citybuzz -
Aditxt names Evofem CEO to its board, eyes women’s health market By Investing.com - Investing.com South Africa
Aditxt names Evofem CEO to its board, eyes women’s health market - Investing.com India
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board Of Directors - MarketScreener
Aditxt (ADTX) Welcomes Saundra Pelletier to Its Board | ADTX Stock News - GuruFocus
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors | ADTX Stock News - GuruFocus
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, - GuruFocus
Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, Co-CEO Of Adimune, And Chris Mitton, President Of Pearsanta, Will Join Aditxt Weekly Update On June 6 - MarketScreener
Saundra Pelletier, Evofem Biosciences’ CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6 - Bluefield Daily Telegraph
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Aditxt (NASDAQ:ADTX) Shares Down 8.1% – Time to Sell? - Defense World
Aditxt Highlights Strategic Partnership with Evofem Biosciences - TipRanks
ADTX stock plunges to 52-week low, touches $1.5 amid steep decline By Investing.com - Investing.com South Africa
ADTX stock plunges to 52-week low, touches $1.5 amid steep decline - Investing.com Nigeria
Finanzdaten der Aditxt Inc-Aktie (ADTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aditxt Inc-Aktie (ADTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Oct 16 '24 |
Sale |
1.17 |
25,534 |
29,875 |
0 |
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):